Molecular Devices recently announced it opened its custom-built bioanalytical site in the U.K. The new facility is based in Cardiff, Wales, and is custom-built for the company’s bioprocess workflow and unique bioreactor technology. Molecular Devices’ biotechnology allows pharmaceutical companies to manufacture patient-derived organoids (PDOs) at scale in a quality-controlled manner. “Molecular Devices is the only…